VHA and UHC Merge Purchasing Programs
Consolidation in hospital purchasing just took a giant leap forward with the announcement that VHA and University HealthSystems Consortium will create a joint supply chain management program. For suppliers, who have seen other large-scale mergers of customers, the question has become, when is big, too big?
You may also be interested in...
In a significant development, China proposes to strengthen the protection of new drugs through not only patent linkage but also patent compensation in the latest draft of its revised Patent Law.
Hedge fund Davidson Kempner is recommending that Qiagen NV renegotiate its planned takeover deal with Thermo Fisher Scientific, arguing that demand for diagnostic fueled by the COVID-19 pandemic makes Qiagen worth more than the price agreed on in March. See what Davidson Kempner’s partner Michael Herzog said about it here.
Neutralizing antibodies were seen in all 45 people injected across three dose levels in the first-in-human study. The middle dose of 100mcg will be tested in the company’s Phase III trial starting 27 July.